Thomas Shrader
Stock Analyst at BTIG
(4.35)
# 1,310
Out of 5,010 analysts
719
Total ratings
40.4%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IVVD Invivyd | Maintained: Buy | $10 | $0.8501 | +1,076.33% | 9 | Sep 30, 2026 | |
| NTHI NeOnc Technologies Holdings | Reiterated: Buy | $15 | $3.30 | +354.55% | 3 | Sep 28, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $23 → $20 | $13.70 | +45.99% | 13 | Sep 24, 2026 | |
| TLSA Tiziana Life Sciences | Reiterated: Buy | $7 | $0.9537 | +633.98% | 2 | Sep 21, 2026 | |
| ABOS Acumen Pharmaceuticals | Reiterated: Buy | $8 | $2.25 | +256.35% | 30 | Sep 16, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterated: Buy | $10 | $2.92 | +242.47% | 16 | Sep 14, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $8 | $2.08 | +284.62% | 3 | Sep 10, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $12 | $4.96 | +142.18% | 9 | Sep 9, 2026 | |
| HROW Harrow | Reiterated: Buy | $63 | $31.40 | +100.64% | 13 | Aug 25, 2026 | |
| ACIU AC Immune | Reiterated: Buy | $8 | $2.60 | +207.69% | 8 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 → $37 | $26.58 | +39.20% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $5.03 | +218.09% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.68 | +197.62% | 30 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $20.81 | +87.41% | 38 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $7.14 | +460.22% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $25.88 | +50.70% | 31 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $89 | $56.69 | +56.99% | 27 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $227.07 | - | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $25 | $12.96 | +92.90% | 15 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $10.82 | +75.60% | 8 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.87 | +220.86% | 25 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $147 | $49.74 | +195.54% | 6 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.54 | +57.48% | 17 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.32 | +581.82% | 33 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $13.29 | +20.39% | 28 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.96 | - | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $10.64 | n/a | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.38 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.51 | n/a | 14 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $0.0001 | n/a | 6 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $1.08 | n/a | 16 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.37 | n/a | 5 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $65.97 | n/a | 20 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $15 | $10.80 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.13 | n/a | 5 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.35 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $216 | $9.53 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $12 | $3.77 | n/a | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.62 | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $15.23 | n/a | 2 | Mar 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $25.00 | n/a | 4 | Mar 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $57 → $70 | $25.65 | n/a | 5 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.51 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.15 | n/a | 4 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $6.18 | n/a | 5 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $13.00 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.00001 | n/a | 3 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $1.38 | n/a | 4 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.24 | n/a | 9 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.64 | n/a | 8 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $16.10 | n/a | 1 | Oct 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $39 | $8.05 | n/a | 12 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $26 | $7.24 | n/a | 4 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $30.00 | n/a | 4 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $40 | $14.15 | n/a | 5 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $76 | $50.37 | n/a | 3 | Oct 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.11 | n/a | 17 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $130 | $9.78 | n/a | 7 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 | $0.0003 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $38 | $6.79 | n/a | 9 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.2 → $11 | $2.50 | n/a | 4 | Dec 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $151.28 | n/a | 1 | Mar 23, 2015 |
Invivyd
Sep 30, 2026
Maintained: Buy
Price Target: $10
Current: $0.8501
Upside: +1,076.33%
NeOnc Technologies Holdings
Sep 28, 2026
Reiterated: Buy
Price Target: $15
Current: $3.30
Upside: +354.55%
Arcturus Therapeutics Holdings
Sep 24, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $13.70
Upside: +45.99%
Tiziana Life Sciences
Sep 21, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9537
Upside: +633.98%
Acumen Pharmaceuticals
Sep 16, 2026
Reiterated: Buy
Price Target: $8
Current: $2.25
Upside: +256.35%
NRx Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $10
Current: $2.92
Upside: +242.47%
Serina Therapeutics
Sep 10, 2026
Reiterated: Buy
Price Target: $8
Current: $2.08
Upside: +284.62%
Opus Genetics
Sep 9, 2026
Reiterated: Buy
Price Target: $12
Current: $4.96
Upside: +142.18%
Harrow
Aug 25, 2026
Reiterated: Buy
Price Target: $63
Current: $31.40
Upside: +100.64%
AC Immune
Aug 20, 2026
Reiterated: Buy
Price Target: $8
Current: $2.60
Upside: +207.69%
Aug 13, 2026
Rated: Buy
Price Target: $28 → $37
Current: $26.58
Upside: +39.20%
Aug 11, 2026
Reiterated: Buy
Price Target: $16
Current: $5.03
Upside: +218.09%
Aug 11, 2026
Reiterated: Buy
Price Target: $5
Current: $1.68
Upside: +197.62%
Aug 6, 2026
Reiterated: Buy
Price Target: $39
Current: $20.81
Upside: +87.41%
Aug 5, 2026
Reiterated: Buy
Price Target: $40
Current: $7.14
Upside: +460.22%
Aug 3, 2026
Reiterated: Buy
Price Target: $39
Current: $25.88
Upside: +50.70%
Jul 29, 2026
Reiterated: Buy
Price Target: $89
Current: $56.69
Upside: +56.99%
Jul 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $227.07
Upside: -
Jul 7, 2026
Reiterated: Buy
Price Target: $14 → $25
Current: $12.96
Upside: +92.90%
Jun 11, 2026
Reiterated: Buy
Price Target: $19
Current: $10.82
Upside: +75.60%
Apr 2, 2026
Reiterated: Buy
Price Target: $6
Current: $1.87
Upside: +220.86%
Mar 30, 2026
Reiterated: Buy
Price Target: $147
Current: $49.74
Upside: +195.54%
Mar 26, 2026
Reiterated: Buy
Price Target: $4
Current: $2.54
Upside: +57.48%
Mar 17, 2026
Reiterated: Buy
Price Target: $9
Current: $1.32
Upside: +581.82%
Nov 17, 2025
Reiterated: Buy
Price Target: $16
Current: $13.29
Upside: +20.39%
Nov 3, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.96
Upside: -
Jul 21, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $10.64
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.38
Upside: n/a
Mar 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.51
Upside: n/a
Mar 19, 2024
Reiterated: Buy
Price Target: $32
Current: $0.0001
Upside: n/a
Feb 28, 2024
Reiterated: Buy
Price Target: $33
Current: $1.08
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.37
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $65.97
Upside: n/a
Nov 14, 2023
Rated: Buy
Price Target: $32 → $15
Current: $10.80
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $4.13
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $3.35
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $216
Current: $9.53
Upside: n/a
Mar 20, 2023
Rated: Buy
Price Target: $50 → $12
Current: $3.77
Upside: n/a
Mar 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.62
Upside: n/a
Mar 12, 2023
Rated: Buy
Price Target: $20
Current: $15.23
Upside: n/a
Mar 5, 2023
Reiterated: Buy
Price Target: $56
Current: $25.00
Upside: n/a
Mar 2, 2023
Rated: Buy
Price Target: $57 → $70
Current: $25.65
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $25.51
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Sep 9, 2021
Rated: Buy
Price Target: $16
Current: $6.18
Upside: n/a
Aug 6, 2021
Reiterated: Buy
Price Target: $60
Current: $13.00
Upside: n/a
Jul 6, 2021
Rated: Buy
Price Target: $10
Current: $0.00001
Upside: n/a
Jun 10, 2021
Reiterated: Buy
Price Target: $5.5
Current: $1.38
Upside: n/a
Jun 4, 2021
Rated: Hold
Price Target: n/a
Current: $1.24
Upside: n/a
May 10, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.64
Upside: n/a
Sep 23, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.00
Upside: n/a
Oct 6, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $16.10
Upside: n/a
Nov 9, 2017
Reiterated: Buy
Price Target: $57 → $39
Current: $8.05
Upside: n/a
Nov 7, 2017
Reiterated: Buy
Price Target: $32 → $26
Current: $7.24
Upside: n/a
Nov 1, 2017
Reiterated: Buy
Price Target: $14 → $12
Current: $30.00
Upside: n/a
Oct 17, 2017
Reiterated: Buy
Price Target: $20 → $40
Current: $14.15
Upside: n/a
Oct 10, 2017
Reiterated: Buy
Price Target: $35 → $76
Current: $50.37
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $11
Current: $1.11
Upside: n/a
Oct 2, 2017
Rated: Buy
Price Target: $110 → $130
Current: $9.78
Upside: n/a
Jun 30, 2017
Downgraded: Hold
Price Target: $6
Current: $0.0003
Upside: n/a
Jun 21, 2017
Reiterated: Buy
Price Target: $32 → $38
Current: $6.79
Upside: n/a
Dec 22, 2016
Reiterated: Hold
Price Target: $1.2 → $11
Current: $2.50
Upside: n/a
Mar 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $151.28
Upside: n/a